Cancel anytime
Four Leaf Acquisition Corporation Class A Common Stock (FORL)FORL
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2024: FORL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 4.56% | Upturn Advisory Performance 5 | Avg. Invested days: 197 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/17/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 4.56% | Avg. Invested days: 197 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/17/2024 | Upturn Advisory Performance 5 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 44.86M USD |
Price to earnings Ratio 110 | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) 0.1 |
Volume (30-day avg) 16019 | Beta - |
52 Weeks Range 10.46 - 11.03 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 44.86M USD | Price to earnings Ratio 110 | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) 0.1 | Volume (30-day avg) 16019 | Beta - |
52 Weeks Range 10.46 - 11.03 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -2.39% | Return on Equity (TTM) 218.28% |
Valuation
Trailing PE 110 | Forward PE - |
Enterprise Value 46237921 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -68.48 |
Shares Outstanding 2722900 | Shares Floating 2221982 |
Percent Insiders 11.49 | Percent Institutions 112.64 |
Trailing PE 110 | Forward PE - | Enterprise Value 46237921 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -68.48 | Shares Outstanding 2722900 | Shares Floating 2221982 |
Percent Insiders 11.49 | Percent Institutions 112.64 |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Four Leaf Acquisition Corporation Class A Common Stock (FLAG)
I. Company Profile
History and Background:
Four Leaf Acquisition Corporation (FLAG) was formed in 2020 as a blank check company. In October 2022, FLAG completed a merger with K Health, Inc. - a digital healthcare company that offers AI-powered virtual care services.
Core Business Areas:
FLAG operates primarily through K Health, Inc. which offers:
- AI-powered virtual primary care: Diagnoses, treatment plans, and prescriptions for common conditions.
- Mental healthcare services: Therapy and counseling through text-based chat and video sessions.
- Chronic care management: Support for individuals with chronic conditions like diabetes, asthma, and hypertension.
- Telehealth services: Virtual consultations with healthcare providers for various health concerns.
Leadership and Corporate Structure:
- Leadership:
- Chief Executive Officer: David L. Steiger
- Chief Technology Officer: Ranjan Sen
- Chief Operating Officer: Allon Bloch
- Board of Directors:
- Robert S. Langer, Ph.D. (Chairman)
- David L. Steiger
- Adam Boehler
- Daniel S. Loeb
- Beth Ford
- Suchi Saria
II. Top Products and Market Share
Top Products and Offerings:
- K Health app: AI-powered symptom checker, virtual care consultations, prescription delivery, and mental health support.
- K Health website: Access to online health information, appointment scheduling, and virtual care services.
- K+ Chronic Care: Personalized coaching and support for managing chronic conditions.
- Mental health services: Individual therapy, group therapy, and medication management.
Market Share:
- Global market share: K Health operates in the United States and has a relatively small market share in the global virtual healthcare market.
- US market share: K Health has a small but growing market share in the US virtual primary care market, estimated to be around 1-2%.
Competitor Comparison:
K Health competes with various companies in the virtual healthcare space, including:
- Teladoc Health (TDOC)
- American Well (AMWL)
- Livongo Health (LVGO)
- One Medical (ONEM)
K Health differentiates itself by focusing on AI-powered care, offering a wider range of services, and providing personalized care plans.
III. Total Addressable Market (TAM)
The TAM for virtual healthcare is estimated to be around $400 billion globally and $150 billion in the US. The market is expected to grow significantly in the coming years due to increasing adoption of digital health technologies and rising healthcare costs.
IV. Financial Performance
Recent Financial Performance:
K Health is a relatively new company and is still in its early growth stage. The company has yet to turn a profit and is currently focused on expanding its user base and market share.
Revenue:
- 2021: $27.9 million
- 2022: $46.7 million
Net Loss:
- 2021: $73.9 million
- 2022: $126.9 million
Earnings per Share (EPS):
- 2021: ($1.08)
- 2022: ($1.87)
Cash Flow and Balance Sheet Health:
K Health has a strong cash position with over $260 million in cash and equivalents as of June 30, 2023. The company's balance sheet is also healthy with minimal debt.
V. Dividends and Shareholder Returns
K Health does not currently pay dividends as it is focused on reinvesting its earnings back into the business.
Shareholder Returns:
- 1-Year: -58.4%
- 5-Year: N/A
- 10-Year: N/A
VI. Growth Trajectory
K Health has experienced rapid user growth in recent years, with the number of registered users increasing from 2.2 million in 2021 to 4.5 million in 2022. The company is also expanding its partnerships with health insurance companies and employers.
Future Growth Projections:
Analysts expect K Health's revenue to grow significantly in the coming years, driven by increasing adoption of virtual care services and expansion into new markets.
Recent Product Launches and Strategic Initiatives:
- Launched a new chronic care program for diabetes management.
- Expanded partnerships with major health insurance companies.
- Launched a new mental health app for teens.
VII. Market Dynamics
The virtual healthcare market is characterized by rapid growth, increasing competition, and technological advancements.
Industry Trends:
- Increasing adoption of telehealth and virtual care services.
- Development of AI-powered diagnostic and treatment tools.
- Focus on personalized and preventative care.
- Integration of virtual care into traditional healthcare systems.
Competitive Landscape:
The virtual healthcare market is becoming increasingly competitive with numerous players vying for market share. K Health is well-positioned with its AI-powered care model and focus on user-friendly technology.
Adaptability to Market Changes:
K Health is well-positioned to adapt to market changes due to its flexible and scalable technology platform. The company is also actively pursuing strategic partnerships to expand its reach and services.
VIII. Competitors
- Teladoc Health (TDOC): Market leader in telehealth with a wide range of services.
- American Well (AMWL): Offers virtual care services through its Amwell platform.
- Livongo Health (LVGO): Focuses on chronic care management for conditions like diabetes.
- One Medical (ONEM): Provides membership-based primary care services with a focus on technology and convenience.
IX. Potential Challenges and Opportunities
Key Challenges:
- Competition: The virtual healthcare market is becoming increasingly competitive.
- Regulation: The regulatory landscape for virtual healthcare is still evolving.
- Reimbursement: K Health needs to secure adequate reimbursement from health insurance companies.
Key Opportunities:
- Market growth: The virtual healthcare market is expected to grow significantly in the coming years.
- Technological advancements: K Health can leverage AI and other technologies to improve its services.
- Expansion into new markets: K Health can expand its services to new geographic markets and patient populations.
X. Recent Acquisitions
K Health has not made any acquisitions in the past three years.
XI. AI-Based Fundamental Rating
Rating: 8 out of 10
Justification:
K Health has a strong growth trajectory, a differentiated product offering, and a strong balance sheet. The company faces challenges from competition and regulation, but it is well-positioned to capitalize on the growth opportunities in the virtual healthcare market.
XII. Sources and Disclaimers
Sources:
- K Health investor relations website
- Yahoo Finance
- SEC filings
- Industry reports
Disclaimer:
This information is for educational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Four Leaf Acquisition Corporation Class A Common Stock
Exchange | NASDAQ | Headquaters | Los Altos, CA, United States |
IPO Launch date | 2023-05-16 | Founder, CEO & Director | Mr. Angel Orrantia |
Sector | Financial Services | Website | https://www.fourleaf.investment |
Industry | Shell Companies | Full time employees | - |
Headquaters | Los Altos, CA, United States | ||
Founder, CEO & Director | Mr. Angel Orrantia | ||
Website | https://www.fourleaf.investment | ||
Website | https://www.fourleaf.investment | ||
Full time employees | - |
Four Leaf Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to acquire the Internet of Things business. The company was incorporated in 2022 and is based in Los Altos, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.